Company CVAbout Morepen Laboratories Ltd 
Morepen Laboratories Ltd
Small Cap
Pharmaceuticals & Drugs
Morepen Laboratories Limited is an India-based pharmaceutical company. Its products include Loratadine, Montelukast Sodium, Atorvastatin Calcium and Sultamicillin. The company markets formulation products in various therapeutic categories, such as antibiotics, gastrointestinal, respiratory, analgesic, antiallergic and neuropsychiatry with brands, such as Saltum, Saltumax, Cefpopen, Cefpen-S, Dom-DT, Acifix, Rabipen- DSR and Montelast.
Company Coordinates
Company Details
Morepen Village, Nalagarh Road Near Baddi Solan Himachal Pradesh : 173205
Registrar Details
MAS Services Ltd, T-34 , 2nd Floor, Okhla Industrial Area, Phase - II, New Delhi
Capital StructureCapital Structure
Present Equity Capital
INR 109.59 Cr
Number of Shares
54.8 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
05-Aug-2024
54.8
109.59
36784991
2
Qualified Institutional Placement
21-Sep-2022
51.12
102.23
12000000
2
Conversion of Warrants
27-May-2022
49.92
99.83
21342505
2
Preferential basis
30-Mar-2022
47.78
95.57
28000000
2
Conversion of Warrants
28-Apr-2021
55.83
111.67
108500000
10
Preferential issue/warr.conversion
28-Apr-2021
55.83
111.67
108500000
2
Preferential issue/warr.conversion
31-Dec-2011
44.98
89.97
76988
2
Unspecified
31-Dec-2011
44.98
89.97
76988
2
Unspecified
30-Sep-2011
44.97
89.95
398977
2
Unspecified
30-Sep-2011
44.97
89.95
398977
2
Unspecified
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 2 Schemes (0.0%)
FIIs
Held by 44 FIIs (2.22%)
Promoter with highest holding
Scope Credits And Financial Services Pvt. Ltd. (2.84%)
Highest Public shareholder
Pinfold Overseas Limited (7.03%)
Individual Investors Holdings
48.35%
Board of Directors
Management
Designation
Remuneration
Sushil Suri
Chairman & Managing Director
4.77 cr
Manoj Joshi
Non-Exec. & Independent Dir.
4.65 lacs
Bhupender Raj Wadhwa
Non-Exec. & Independent Dir.
5.75 lacs
Sukhcharan singh
Non-Exec. & Independent Dir.
6.25 lacs
Vipul Kumar Srivatava
Company Sec. & Compli. Officer
0
Sanjay Suri
Whole-time Director
1.81 cr
Praveen Kumar Dutt
Non-Exec. & Independent Dir.
5.45 lacs
Savita
Non-Exec. & Independent Dir.
3.75 lacs
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Other Operating Revenues - Other Items
0.33
0.05%
Other Operating Revenues - Other Items
Other Operating Revenues - Other Items
Stock DNARevenue and Profits:
Net Sales:
453 Cr
(Quarterly Results - Dec 2024)
Net Profit:
27 Cr
Pharmaceuticals & Drugs
INR 2,753 Cr (Small Cap)
21.00
33
0.00%
-0.14
11.82%
2.37
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
